Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant.
Epigral Limited (EPIGRAL) is listed on the NSE in the Basic Materials sector, Chemicals industry. The EPIGRAL share price is ₹913.15 (-3.77% today), with a market capitalisation of ₹39B and a price-to-earnings (P/E) ratio of 13.8. MarketRipple tracks the EPIGRAL investment thesis, the ripple-chain impact of market events on Epigral Limited, and the Basic Materials sector outlook.
Open
₹918.00
High
₹925.90
Low
₹904.80
Prev. Close
₹948.90
52W High
₹1,669.40
52W Low
₹807.00
Day range
₹904.80–₹925.90
52-week range
₹807.00–₹1,669.40
Volume
10K
P/E
13.8
ROE
12.8%
D/E
0.26
Margin
10.2%
Epigral Limited (NSE: EPIGRAL) is currently trading at ₹913.15 (-3.77%).
Epigral Limited's market capitalization is ₹39B.
Epigral Limited's price-to-earnings (P/E) ratio is 13.8.
Epigral Limited operates in the Basic Materials sector (Chemicals).
Analyst consensus on Epigral Limited currently reads neutral, based on 2 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.